Key indicators: single-crystal X-ray study; T = 100 K; mean (C-C) = 0.002 Å; R factor = 0.034; wR factor = 0.087; data-to-parameter ratio = 13.9.
Related literature
For the crystal structure of the monoclinic form of the title compound, see: Warzecha et al. (2006b) . For a photochemical study of the title compound, see : Warzecha, Gö rner et al. (2006) . For related compounds, see: Lü et al. (2006) ; Warzecha et al. (2006a) ; Chen et al. (2006) . For graph-set motifs, see: Etter (1990) .
Experimental
Crystal data Table 1 Hydrogen-bond geometry (Å , ). 
Data collection: CrystalClear-SM Expert (Rigaku/MSC, 2009 ); cell refinement: CrystalClear-SM Expert; data reduction: CrystalClear-SM Expert; program(s) used to solve structure: SIR97 (Altomare et al., 1999) ; program(s) used to refine structure: SHELXL97 (Sheldrick, 2008) ; molecular graphics: Yadokari-XG 2009 (Kabuto et al., 2009 ), ORTEP-3 (Farrugia, 1997 and Mercury (Macrae et al., 2008) ; software used to prepare material for publication: PLATON (Spek, 2009) and publCIF (Westrip, 2010 Warzecha, et al. (2006b) reported the crystal structure of the monoclinic form of title compound, which was obtained from an ethanolic solution. Herein, the crystal structure of a triclinic form obtained from a dimethylformamide solution is described. The molecule (Fig. 1) , consists of two planar subunits, i.e. a phthalimide moiety and a benzene ring, being linked by a sp 3 -C9 atom so that the molecular conformation is characterized by the N1-C9-C10-C11 and N1-C9-C10-C15 torsion angles. Torsion angle corresponding to N1-C9-C10-C11 in the monoclinic form is 153.41 (14)° whereas that of the triclinic form is -82.66 (14)°. The torsion angle in the triclinic form is almost the same as the triclinic form of N-benzylphthalimide [86.9 (3)°, Lü et al., 2006 and -86.82 (16)°, Warzecha et al., 2006a] and N-(4-methlybenzyl)phthalimide [84.2 (3)°, Chen et al., 2006] .
In the crystal structure of the triclinic form ( (Etter, 1990) , respectively, while in the triclinic form, C aryl -H···O=C and C alkyl -H···O=C interactions form C(8) and C(11) infinite chain structures ( Fig. 3 and Table 1 ), respectively.
Reagents for the synthesis were from Tokyo Chemical Industry Co. and they were used without additional purification. A mixture of potassium phthalimide (0.926 g, 5 mmol) and 4-methoxybenzyl chloride (0.80 g, 5.1 mmol) in dimethylformamide (5 ml) was stirred at ambient temperature. The resulting suspension became a clear solution after 2 h. The solution was allowed to stand for a further 12 h without stirring. Several colourless platelet single crystals were deposited and used for X-ray analysis and then the crystal shape changed from platelet into needle for another 12 h. The resulting needle crystal was isolated by filtration, and successively washed with cold water and EtOH. Recrystallization from EtOH yielded colourless needle crystals (1.07 g, 80%, m.p. 403 K). The melting point of the platelet crystal was also 403 K. The cell parameters of a needle crystal corresponded to the monoclinic form.
Refinement
The H atoms of the methoxy group were positioned with idealized geometry with C-H = 0.98 Å and refined as riding with U iso (H) = 1.5U eq (C16). All other H atoms were located in a difference Fourier map and refined freely with U iso (H) = 1.2U eq (C). (Kabuto et al., 2009 ), ORTEP-3 (Farrugia, 1997 and Mercury (Macrae et al., 2008) ; software used to prepare material for publication: PLATON (Spek, 2009) and publCIF (Westrip, 2010) .
Figure 1
The molecular structure of the title compound, showing displacement ellipsoids at the 50% probability level; H atoms are shown as circles of arbitrary size. 
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (

